Allendorf John, Kim Lucy, Chabot John, DiGiorgi Mary, Spanknebel Katherine, LoGerfo Paul
Department of Surgery, College of Physicians and Surgeons of Columbia University, New York Presbyterian Hospital, New York, New York 10032, USA.
J Clin Endocrinol Metab. 2003 Jul;88(7):3015-8. doi: 10.1210/jc.2002-021095.
Although sestamibi scanning has been shown to have greater sensitivity and specificity than other preoperative localization techniques for parathyroid adenoma, it is unclear whether preoperative scanning improves outcomes for parathyroid surgery. Data from 528 consecutive patients who underwent neck exploration for primary hyperparathyroidism by one surgeon were collected prospectively over a 5-yr period. Patients were classified by preoperative scanning status (no scan, positive scan, and negative scan), and outcomes were compared in terms of operative time, length of hospital stay, and cure rate. Patients who had undergone a previous parathyroid operation and patients who received alternate preoperative localization techniques (ultrasound, magnetic resonance imaging, and computed tomography) were excluded from the study. All scans were ordered by the referring physician-the surgeon made no recommendations for preoperative scanning. All groups were similar in terms of gender, age, anesthesia class, body habitus, and complication rate. There was no significant difference in cure rate between patients who had preoperative scanning (97.5%) vs. those who did not (99.3%); however, there was a significant difference in cure rate between the negative-scan group (92.7%) and the positive and no-scan groups (99.3%, P < 0.01). In patients without concomitant thyroid surgery, there was no significant difference in operative time between the no scan (42.4 +/- 14.9 min) vs. the all-scan group (40.2 +/- 15.2 min); however, there was a significant difference between the negative scan group (44.5 +/- 21.9 min) and the positive scan group (38.5 +/- 12.6 min, P < 0.01). There was no significant difference in length of hospital stay among the three groups. These results suggest that, although preoperative sestamibi scanning does not alter the outcome of parathyroid surgery, it does identify those patients who are less likely to be cured.
虽然已证明锝-甲氧基异丁基异腈扫描对于甲状旁腺腺瘤的敏感性和特异性高于其他术前定位技术,但术前扫描是否能改善甲状旁腺手术的预后尚不清楚。在5年期间前瞻性收集了由一位外科医生为原发性甲状旁腺功能亢进症进行颈部探查的528例连续患者的数据。根据术前扫描状态(未扫描、扫描阳性和扫描阴性)对患者进行分类,并比较手术时间、住院时间和治愈率等结果。曾接受过甲状旁腺手术的患者以及接受其他术前定位技术(超声、磁共振成像和计算机断层扫描)的患者被排除在研究之外。所有扫描均由转诊医生开具——外科医生未对术前扫描提出建议。所有组在性别、年龄、麻醉分级、体型和并发症发生率方面相似。术前扫描的患者(97.5%)与未进行术前扫描的患者(99.3%)之间的治愈率无显著差异;然而,扫描阴性组(92.7%)与扫描阳性组和未扫描组(99.3%,P<0.01)之间的治愈率存在显著差异。在未同时进行甲状腺手术的患者中,未扫描组(42.4±14.9分钟)与所有扫描组(40.2±15.2分钟)之间的手术时间无显著差异;然而,扫描阴性组(44.5±21.9分钟)与扫描阳性组(38.5±12.6分钟,P<0.01)之间存在显著差异。三组之间的住院时间无显著差异。这些结果表明,虽然术前锝-甲氧基异丁基异腈扫描不会改变甲状旁腺手术的结果,但它确实能识别出那些治愈可能性较小的患者。